# Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease

> **NCT00279019** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 31 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GSK233705
- **DRUG:** Tiotropium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00279019
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12-12
- **Primary completion:** 2006-06-13
- **Final completion:** 2006-06-13
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00279019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00279019, "Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00279019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*